Johannes Zuber
机构: Group Leader - IMP (Research Institute of Molecular Pathology), Vienna, Austria
主页: imp.ac.at
每年引用次数
引用次数
引用: 22,601
H-指数: 70
I10-指数 : 146
出版物: 268
XIAP is an Attractive Therapeutic Target for all as Validated in Innovative Genetically Engineered Patient-Derived Xenograft Models
I. Jeremias , M. Carlet , J. Vergalli , J. Zuber
Annals of Hematology
2017
Parallel PRC2/cPRC1 and vPRC1 pathways silence lineage-specific genes and maintain self-renewal in mouse embryonic stem cells.
J. A. Zepeda-Martinez , C. Pribitzer , J. Wang , D. Bsteh
Science Advances 6 ( 14)
11
2020
A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions
W. Xue , T. Kitzing , S. Roessler , J. Zuber
Proceedings of the National Academy of Sciences of the United States of America 109 ( 21) 8212 -8217
107
2012
An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance
J. Zuber , A. R. Rappaport , W. Luo , E. Wang
Genes & Development 25 ( 15) 1628 -1640
203
2011
Mouse models of human AML accurately predict chemotherapy response
J. Zuber , I. Radtke , T. S. Pardee , Z. Zhao
Genes & Development 23 ( 7) 877 -889
307
2009
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
S. P. Glaser , E. F. Lee , E. Trounson , P. Bouillet
Genes & Development 26 ( 2) 120 -125
266
2012
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal
Z. Zhao , J. Zuber , E. Diaz-Flores , L. Lintault
Genes & Development 24 ( 13) 1389 -1402
188
2010
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
J. Shi , W. A. Whyte , C. J. Zepeda-Mendoza , J. P. Milazzo
Genes & Development 27 ( 24) 2648 -2662
424
2013
Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia
G. J. Liu , L. Cimmino , J. G. Jude , Y. Hu
Genes & Development 28 ( 12) 1337 -1350
61
2014
Regulation of NO Synthesis, Local Inflammation, and Innate Immunity to Pathogens by BET Family Proteins
S. Wienerroither , I. Rauch , F. Rosebrock , A. M. Jamieson
Molecular and Cellular Biology 34 ( 3) 415 -427
48
2014
Reversible suppression of an essential gene in adult mice using transgenic RNA interference
K. McJunkin , A. Mazurek , P. K. Premsrirut , J. Zuber
Proceedings of the National Academy of Sciences of the United States of America 108 ( 17) 7113 -7118
42
2011
X-Linked inhibitor of apoptosis protein (XIAP) exhibits an essential role of patients' acute lymphoblastic leukemia cells growing in vivo
J. Vergalli , M. Carlet , T. Hoffmann , M. Roth
European Journal of Cancer 69
1
2016
A genome-wide CRISPR/Cas9 screen to identify phagocytosis modulators in monocytic THP-1 cells
Lindner , Benjamin and Martin , Eva and Steininger , Monika and Bundalo
Scientific Reports 11 ( 1) 12973
6
2021
Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancers
Bruce Stillman , Scott W Lowe , Anthony Mazurek , Johannes Ekkehart Zuber
13
2014
Identification of rnai targets and use of rnai for rational therapy of chemotherapy-resistant leukemia and other cancers
Bruce Stillman , Scott W Lowe , Anthony Mazurek , Johannes Ekkehart Zuber
2015
High throughput methods for functionally determining rna interference efficiency
Christof Fellmann , Scott W Lowe , Gregory J Hannon , Johannes Ekkehart Zuber
2015
Globale Analyse der Genexpression nach maligner Transformation durch das Onkogen HRAS
Johannes Ekkehart Zuber
Verlag nicht ermittelbar
2003
High throughput methods for functionally determining RNA interference efficiency
Christof Fellmann , Scott W Lowe , Gregory J Hannon , Johannes E Zuber
3
2014
Compositions and methods for treating leukemia
Christopher R. Vakoc , Junwei Shi , Johannes Zuber , James Elliott Bradner
52
2011
Effective use of high-dose chemotherapy and autologous stem cell rescue for relapsed adult Wilms' tumor and a novel alteration in intron 1 of the WT1 gene.
Brigitte Royer-Pokora , Markus Y Mapara , Michail Plotkin , Bert Hildebrandt
Journal of Pediatric Hematology Oncology 26 ( 12) 820 -823
3
2004